| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $290.6M | $261.7M | $251.7M |
| YoY Revenue Growth % | +11.0% | +4.0% | — |
| Gross Profit | $230.5M | $210.3M | — |
| Gross Margin % | 79.3% | 80.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $47.1M | $44.0M | $38.6M |
| Operating Margin % | 16.2% | 16.8% | 15.4% |
| Net Income (GAAP) | $42.1M | $50.1M | $40.0M |
| EBITDA (Normalized) | $63.2M | $53.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $84.9M | $90.5M | $44.5M |
| Capital Expenditures (CapEx) | $20.1M | $12.3M | — |
| Free Cash Flow (FCF) | $64.8M | $78.2M | $44.5M |
| FCF Margin % | 22.3% | 29.9% | 17.7% |
| Return on Invested Capital (ROIC %) | 26.5% | 25.4% | — |
| Cash & Short-Term Equivalents | $71.1M | $95.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $211.5M | $231.8M | — |